Clinical Trials in Atlanta

Showing 2621-2640 of 9,468 trials

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

NCT05701774

The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.

Prader-Willi Syndrome

Soleno Therapeutics, Inc.83 participantsStarted Jan 2023

Orange, California, United States • Palo Alto, California, United States • San Diego, California, United States +19 more locations

Active Not RecruitingPhase 1/2< 1 mile

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT05747924

A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

FSHDFSHD1FSHD2+24 more

Avidity Biosciences, Inc.90 participantsStarted Apr 2023

Los Angeles, California, United States • Palo Alto, California, United States • San Diego, California, United States +14 more locations

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Find Trials by Condition in Atlanta

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)

The DETOUR 2 Clinical Trial

Strategy to Avoid Excessive Oxygen in Major Burn Patients

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure

Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab

Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD

EFS of Bioabsorbable Implant for NSD

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)